Literature DB >> 11898522

Migration and invasion in brain neoplasms.

A J Bolteus1, M E Berens, G J Pilkington.   

Abstract

Local invasion of the brain by neoplastic glial cells is a major obstacle to effective treatment of intrinsic brain tumors. Invasion is directly related to histologic malignancy, but occurs to some extent irrespective of tumor grade. Because the brain-to-tumor interface is not well demarcated, total surgical removal is rarely possible; moreover, as invading cells transiently arrest from cell division they are refractory to radiotherapeutic intervention. Invading cells may also be protected from the action of cytotoxic drugs by the presence of an intact blood-brain barrier. The invading cells, having migrated several millimeters or even centimeters from the main focus of the tumor, return to cycle phase under the control of some as yet unknown microenvironmental cue to form a recurrent tumor adjacent to the original site of presentation. Recent cellular and genetic information concerning factors underlying invasion may not only yield suitable targets for adaptation of existing therapies, but may also lead to novel approaches in glioma management.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11898522     DOI: 10.1007/s11910-001-0022-x

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  49 in total

1.  Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors.

Authors:  G Velasco; S Cal; A Merlos-Suárez; A A Ferrando; S Alvarez; A Nakano; J Arribas; C López-Otín
Journal:  Cancer Res       Date:  2000-02-15       Impact factor: 12.701

2.  An inverse correlation between expression of NCAM-A and the matrix-metalloproteinases gelatinase-A and gelatinase-B in human glioma cells in vitro.

Authors:  S L Maidment; G J Rucklidge; H K Rooprai; G J Pilkington
Journal:  Cancer Lett       Date:  1997-06-03       Impact factor: 8.679

3.  The role of the extracellular matrix in neoplastic glial invasion of the nervous system.

Authors:  C J Pilkington
Journal:  Braz J Med Biol Res       Date:  1996-09       Impact factor: 2.590

4.  Transforming growth factor-beta1 stimulates contraction of human glioblastoma cell-mediated collagen lattice through enhanced alpha2 integrin expression.

Authors:  K Miyake; S Kimura; M Nakanishi; A Hisada; M Hasegawa; S Nagao; Y Abe
Journal:  J Neuropathol Exp Neurol       Date:  2000-01       Impact factor: 3.685

Review 5.  Expression of hepatocyte growth factor/scatter factor and its receptor c-Met in brain tumors: evidence for a role in progression of astrocytic tumors (Review).

Authors:  T Moriyama; H Kataoka; M Koono; S Wakisaka
Journal:  Int J Mol Med       Date:  1999-05       Impact factor: 4.101

6.  Ets-1 transcription factor-mediated urokinase-type plasminogen activator expression and invasion in glioma cells stimulated by serum and basic fibroblast growth factors.

Authors:  G Kitange; S Shibata; Y Tokunaga; N Yagi; A Yasunaga; M Kishikawa; S Naito
Journal:  Lab Invest       Date:  1999-04       Impact factor: 5.662

7.  Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors.

Authors:  M Nakada; H Nakamura; E Ikeda; N Fujimoto; J Yamashita; H Sato; M Seiki; Y Okada
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

8.  Suppression of CD44 expression decreases migration and invasion of human glioma cells.

Authors:  H Okada; J Yoshida; M Sokabe; T Wakabayashi; M Hagiwara
Journal:  Int J Cancer       Date:  1996-04-10       Impact factor: 7.396

9.  CD44 mediates human glioma cell adhesion and invasion in vitro.

Authors:  A Merzak; S Koocheckpour; G J Pilkington
Journal:  Cancer Res       Date:  1994-08-01       Impact factor: 12.701

10.  Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas.

Authors:  P A Forsyth; H Wong; T D Laing; N B Rewcastle; D G Morris; H Muzik; K J Leco; R N Johnston; P M Brasher; G Sutherland; D R Edwards
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

View more
  26 in total

1.  Stripe-like increase of rCBV beyond the visible border of glioblastomas: site of tumor infiltration growing after neurosurgery.

Authors:  Stella Blasel; Kea Franz; Hanns Ackermann; Stefan Weidauer; Friedhelm Zanella; Elke Hattingen
Journal:  J Neurooncol       Date:  2010-10-07       Impact factor: 4.130

2.  Prognostic value of histological features in diffuse astrocytomas WHO grade II.

Authors:  Tove Lind-Landström; Andreas Hanssøn Habberstad; Stein Sundstrøm; Sverre Helge Torp
Journal:  Int J Clin Exp Pathol       Date:  2012-02-12

3.  Phase II trial of temozolomide plus marimastat for recurrent anaplastic gliomas: a relationship among efficacy, joint toxicity and anticonvulsant status.

Authors:  Morris D Groves; Vinay K Puduvalli; Charles A Conrad; Mark R Gilbert; W K Alfred Yung; Kurt Jaeckle; Vivien Liu; Kenneth R Hess; Kenneth D Aldape; Victor A Levin
Journal:  J Neurooncol       Date:  2006-04-25       Impact factor: 4.130

4.  Assessing the cytoskeletal system and its elements in C6 glioma cells and astrocytes by atomic force microscopy.

Authors:  Dexiang Zhou; Xiaodan Jiang; Ruxiang Xu; Yingqian Cai; Jiliang Hu; Gang Xu; Yuxi Zou; Yanjun Zeng
Journal:  Cell Mol Neurobiol       Date:  2008-03-04       Impact factor: 5.046

Review 5.  Planning for intracavitary anti-EGFR radionuclide therapy of gliomas. Literature review and data on EGFR expression.

Authors:  J Carlsson; Z P Ren; K Wester; A L Sundberg; N E Heldin; G Hesselager; M Persson; L Gedda; V Tolmachev; H Lundqvist; E Blomquist; M Nistér
Journal:  J Neurooncol       Date:  2006-03       Impact factor: 4.130

Review 6.  Cancer stem cells in the mammalian central nervous system.

Authors:  G J Pilkington
Journal:  Cell Prolif       Date:  2005-12       Impact factor: 6.831

7.  Comparative evaluation of preclinical in vivo models for the assessment of replicating retroviral vectors for the treatment of glioblastoma.

Authors:  Juraj Hlavaty; Gerrit Jandl; Melissa Liszt; Helga Petznek; Marielle König-Schuster; Jenny Sedlak; Monika Egerbacher; Jakob Weissenberger; Brian Salmons; Walter H Günzburg; Matthias Renner
Journal:  J Neurooncol       Date:  2010-07-11       Impact factor: 4.130

8.  The Guanine Nucleotide Exchange Factor SWAP-70 Modulates the Migration and Invasiveness of Human Malignant Glioma Cells.

Authors:  Ho Jun Seol; Christian A Smith; Bodour Salhia; James T Rutka
Journal:  Transl Oncol       Date:  2009-12       Impact factor: 4.243

9.  Fibulin-3 is uniquely upregulated in malignant gliomas and promotes tumor cell motility and invasion.

Authors:  Bin Hu; Keerthi K Thirtamara-Rajamani; Hosung Sim; Mariano S Viapiano
Journal:  Mol Cancer Res       Date:  2009-11-03       Impact factor: 5.852

Review 10.  CD133: holy of grail of neuro-oncology or promiscuous red-herring?

Authors:  L K Donovan; G J Pilkington
Journal:  Cell Prolif       Date:  2012-12       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.